Vukovic Vojo

Average Profitability
25.25%
Insider Buys Quantity
9
Insider Buys Sum
$478,981.70
Insider Sells Quantity
2
Insider Sells Sum
$51,867.24

Insider Activity of Vukovic Vojo

According to the SEC Form 4 filings, Vukovic Vojo, being in a position of

  1. Chief Medical Officer at Delcath Systems, Inc.,
    оver the last 12 months, has bought 100000 shares for $268,800, and sold 0 shares,
    over all time since 2023-11-16, has bought 100000 shares for $268,800, and sold 0 shares.

The largest purchase of all time was on 2023-11-16 and amounted to 60000 shares of Delcath Systems, Inc. for $148,800.

The largest sale of all time was on 2011-03-01 and amounted to 5234 shares of Madrigal Pharmaceuticals, Inc. for $27,855.

Biography of Vukovic Vojo

No biography is available at this moment.

2023-12-12PurchaseDelcath Systems, Inc.
DCTH
Chief Medical Officer
40,000
0.1728%
$3.00$120,000+76.71%
2023-11-16PurchaseDelcath Systems, Inc.
DCTH
Chief Medical Officer
60,000
0.3928%
$2.48$148,800+110.53%
2019-08-16PurchaseAileron Therapeutics, Inc.
ALRN
SVP, Chief Medical Officer
75,000
0.2709%
$0.59$44,453+13.56%
2013-06-05PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
20,000
0.0288%
$4.58$91,600+11.17%
2012-06-29PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
6,000
0.0106%
$5.58$33,510+48.08%
2012-03-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
5,110
0.0093%
$4.70$24,012+58.53%
2011-09-02PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
4,376
0.0108%
$4.00$17,504+17.71%
2011-09-01PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
624
0.0015%
$4.07$2,540+10.93%
2011-03-01SaleMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
5,234
0.0126%
$5.32$27,855-10.27%
2010-08-16PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
5,600
0.014%
$2.95$16,520+66.55%
2010-08-12PurchaseMadrigal Pharmaceuticals, Inc.
MDGL
SVP, Chief Medical Officer
1,428
0.0034%
$2.84$4,056+67.12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.